7/22/2014 2:38:15 PM
Skystar Bio-Pharmaceutical, a China veterinary medicine company headquartered in Xi’an, raised $5 million through a private placement. The company said it would use the funds for acquisitions, in-licensing of vaccine and aquaculture products, and R&D, along with general corporate purposes. Before the transaction, Skystar had just under $7 million in cash.
Help employers find you! Check out all the jobs and post your resume.
comments powered by